Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
International Journal of Cancer|April 29, 2006
CD8 T-cell recognition of human 5T4 oncofetal antigenLucy J C Smyth, Eyad Elkord, Taher E I Taher, et al.Frontiers in Immunology|November 29, 2023
Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytesMilena Kalaitsidou, Owen R Moon, Martina Sykorova, et al.JAMA Oncology|October 28, 2016
Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical TrialKarim Chamie, Nicholas M Donin, Pia Klöpfer, et al.Cancer Immunology, Immunotherapy : CII|June 30, 2017
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicityFiona C Thistlethwaite, David E Gilham, Ryan D Guest, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2016
Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell CarcinomaThomas Powles, Mark R Lackner, Stéphane Oudard, et al.The Lancet. Oncology|January 23, 2016
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trialAndrew J Armstrong, Susan Halabi, Tim Eisen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2021
Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell CarcinomaAndrew J Armstrong, Andrew B Nixon, Andrea Carmack, et al.Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|November 12, 2021
Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trialSusan Halabi, Qian Yang, Andrea Carmack, et al.Pageof 8